Obagi Medical Products (OMPI)
Add to Watchlists Create an AlertObagi Medical Products Gross Profit Margin Quarterly:
77.71% for Dec. 31, 2012Obagi Medical Products Historical Gross Profit Margin Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 77.71% |
| Sept. 30, 2012 | 79.79% |
| June 30, 2012 | 79.76% |
| March 31, 2012 | 79.73% |
| Dec. 31, 2011 | 79.17% |
| Sept. 30, 2011 | 79.89% |
| June 30, 2011 | 77.39% |
| March 31, 2011 | 79.40% |
| Dec. 31, 2010 | 78.97% |
| Sept. 30, 2010 | 79.30% |
| June 30, 2010 | 78.50% |
| March 31, 2010 | 79.24% |
| Dec. 31, 2009 | 78.87% |
| Sept. 30, 2009 | 78.91% |
About Gross Profit Margin
A gross profit margin is the difference between sales and the cost of goods sold divided by revenue. This represents the percentage of each dollar of a company's revenue available after accounting for cost of goods sold.
If a company produces phones and earns $32 million in sales but pays $24 million for the items sold, then the company's gross profit margin would be ($32M - $24M) / $32M = 25 percent.
Cutting costs result in higher gross profit margins. If a company sells phones for 500 dollars and the cost of the producing the phone is $250, the current gross profit margin is 50 percent ((500-250)/500). If the company is able to reduce production costs from $250 to $200, the gross profit margin is 60 percent ((500-200)/500).
Note : Profit margins are very dependent on sector. Companies that sell bland potato chips may not have very high margins, but will sell a sizable quantity of potato chips. A company that sells consulting services will likely have higher profit margins, but sell lower quantities.
Learn More
OMPI Gross Profit Margin Quarterly Benchmarks
| Companies | |
|---|---|
| Cadence Pharmaceuticals | 65.41% |
| ARCA biopharma | |
| Sangamo BioSciences |
OMPI Gross Profit Margin Quarterly Rankings
| Overall |
95th percentile 371 of 8009 |
| Sector |
86th percentile 91 of 687 in Healthcare |
| Industry |
81st percentile 45 of 248 in Biotechnology |
OMPI Gross Profit Margin Quarterly Range, Past 5 Years
| Minimum | 77.39% | Jun 2011 |
| Maximum | 81.81% | Jun 2008 |
| Average | 79.28% |